Waters Corporation EPS (Diluted)

EPS (Diluted) of WAT for past 10 years: annual, quarterly and twelve month trailing (TTM) including EPS (Diluted) growth rates and interactive chart. Diluted earnings per share (EPS) tells investors how much of a firm's net income was allotted to each share of common stock. It is reported in a company's income statement and is especially informative for businesses with only common stock in their capital structures. Calculated as net income to common divided by the weighted average number of diluted shares outstanding (takes into account potential dilution from options or share issuance).

Highlights and Quick Summary

  • EPS (Diluted) for the quarter ending December 30, 2020 was 3.49 (a 71.92% increase compared to previous quarter)
  • Year-over-year quarterly EPS (Diluted) increased by 305.81%
  • Annual EPS (Diluted) for 2020 was 8.36 (a -3.8% decrease from previous year)
  • Annual EPS (Diluted) for 2019 was 8.69 (a 13.59% increase from previous year)
  • Annual EPS (Diluted) for 2018 was 7.65 (a 2960.0% increase from previous year)
Visit stockrow.com/WAT for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical EPS (Diluted) of Waters Corporation

Most recent EPS (Diluted)of WAT including historical data for past 10 years.

Interactive Chart of EPS (Diluted) of Waters Corporation

Waters Corporation EPS (Diluted) for the past 10 Years (both Annual and Quarterly)

Year Q1 Q2 Q3 Q4 Fiscal Year
2020 3.49 2.03 1.98 0.86 8.36
2019 3.12 2.07 2.08 1.51 8.69
2018 2.46 1.83 1.98 1.4 7.65
2017 -4.44 1.69 1.63 1.31 0.25
2016 2.15 1.53 1.57 1.15 6.41
2015 1.83 1.4 1.27 1.15 5.65
2014 1.8 1.34 1.13 0.82 5.07
2013 1.65 1.14 1.03 1.39 5.2
2012 2.0 1.12 1.09 0.98 5.19
2011 1.51 1.1 1.07 1.01 4.69
2010 1.36 1.02 0.9 4.06

Business Profile of Waters Corporation

Sector: Healthcare
Industry: Diagnostics & Research
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. Its MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. The company's offers thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company has a collaboration with Genovis AB to develop and market biopharmaceutical characterization workflows based on the its BioAccord LC-MS System, Andrew+ pipetting robot and Genovis SmartEnzymes. Waters Corporation was founded in 1958 and is headquartered in Milford, Massachusetts.